| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors
|
Sehdev, Amikar
|
|
2018
|
82 |
2 |
p. 309-317
|
artikel
|
| 2 |
Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia
|
Gao, Chunlu
|
|
2018
|
82 |
2 |
p. 229-236
|
artikel
|
| 3 |
Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study
|
Iizumi, Sakura
|
|
2018
|
82 |
2 |
p. 275-283
|
artikel
|
| 4 |
Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications
|
Huang, Chengliang
|
|
2018
|
82 |
2 |
p. 171-183
|
artikel
|
| 5 |
Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer
|
Tahara, Junko
|
|
2018
|
82 |
2 |
p. 245-250
|
artikel
|
| 6 |
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients
|
Le Saux, Olivia
|
|
2018
|
82 |
2 |
p. 319-327
|
artikel
|
| 7 |
Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro
|
Huang, Jia-Feng
|
|
2018
|
82 |
2 |
p. 199-210
|
artikel
|
| 8 |
Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel
|
Scarpelli, Matthew
|
|
2018
|
82 |
2 |
p. 211-219
|
artikel
|
| 9 |
Pharmacokinetic and pharmacodynamic bioequivalence study of a pegfilgrastim biosimilar INTP5 in healthy subjects
|
Singh, Inderjeet
|
|
2018
|
82 |
2 |
p. 329-337
|
artikel
|
| 10 |
Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer
|
Rodon, Jordi
|
|
2018
|
82 |
2 |
p. 285-298
|
artikel
|
| 11 |
Phase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma
|
Fruehauf, John P.
|
|
2018
|
82 |
2 |
p. 353-360
|
artikel
|
| 12 |
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors
|
Weekes, Colin D.
|
|
2018
|
82 |
2 |
p. 339-351
|
artikel
|
| 13 |
Pulmonary administration of curcumin inhibits B16F10 melanoma lung metastasis and invasion in mice
|
Shimada, Ken
|
|
2018
|
82 |
2 |
p. 265-273
|
artikel
|
| 14 |
Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma
|
Weng, Jie
|
|
2018
|
82 |
2 |
p. 367
|
artikel
|
| 15 |
Relationship of peak serum methotrexate concentration to prognosis and drug tolerance in non-metastatic extremity osteosarcomas
|
Wang, Bo
|
|
2018
|
82 |
2 |
p. 221-227
|
artikel
|
| 16 |
Reply to: Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma
|
Kaira, Kyoichi
|
|
2018
|
82 |
2 |
p. 369
|
artikel
|
| 17 |
Targeting ALK in pediatric RMS does not induce antitumor activity in vivo
|
Wierdl, Monika
|
|
2018
|
82 |
2 |
p. 251-263
|
artikel
|
| 18 |
The association of polymorphisms in folate-metabolizing genes with response to adjuvant chemotherapy of colorectal cancer
|
Yousef, Al-Motassem
|
|
2018
|
82 |
2 |
p. 237-243
|
artikel
|
| 19 |
The natural agent 4-vinylphenol targets metastasis and stemness features in breast cancer stem-like cells
|
Leung, Hoi-Wing
|
|
2018
|
82 |
2 |
p. 185-197
|
artikel
|
| 20 |
The pH-altering agent omeprazole affects rate but not the extent of ibrutinib exposure
|
Jong, Jan de
|
|
2018
|
82 |
2 |
p. 299-308
|
artikel
|
| 21 |
Therapeutic drug monitoring and dose adaptation of cisplatin in a newborn with hepatoblastoma: a case report
|
Thomas, Fabienne
|
|
2018
|
82 |
2 |
p. 361-365
|
artikel
|
Tijdschrift beschrijving